<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04832230</url>
  </required_header>
  <id_info>
    <org_study_id>2020PBMD02</org_study_id>
    <secondary_id>2020-A01504-35</secondary_id>
    <nct_id>NCT04832230</nct_id>
  </id_info>
  <brief_title>Study of Diagnostic Biomarkers of Acute Acoustic Trauma</brief_title>
  <acronym>BIOTSA</acronym>
  <official_title>Study of Diagnostic Biomarkers of Acute Acoustic Trauma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Direction Centrale du Service de Santé des Armées</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Direction Centrale du Service de Santé des Armées</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Every year, more than two thousand acute acoustic trauma occur in France, equally between the&#xD;
      military and the civilian environment.&#xD;
&#xD;
      Currently, acute acoustic trauma is a pathology with no specific validated treatment, and it&#xD;
      is the cause of many handicapping situations. Improving the future of patients requires a&#xD;
      better understanding of the neurophysiological mechanisms of noise-induced hearing&#xD;
      impairment. They are multiple and pure tone audiometry, the only reference examination, does&#xD;
      not allow to differentiate them. Moreover, in the aftermath of acute acoustic trauma, pure&#xD;
      tone audiometry tends to improve spontaneously, but this recovery is misleading, as a number&#xD;
      of studies in animals have shown that irreversible lesions remain.&#xD;
&#xD;
      The hypothesis of this study is that it is possible to identify new entities, specific to the&#xD;
      type of cochlear lesions, in order to clarify the diagnosis of acute acoustic trauma. These&#xD;
      entities will be identified by the evaluation of noise-induced hearing impairment via a&#xD;
      combination of molecular (proteomic and genomic), physiological and behavioral data. These&#xD;
      diagnostic details may then be used to improve prevention or therapy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2021</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of diagnostic biomarkers of hearing impairment in patients suffering from acute acoustic trauma</measure>
    <time_frame>Through study completion, an average of 3 years</time_frame>
    <description>Machine learning analyses will be performed on the whole collected data to identify diagnostic biomarkers.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Acoustic Trauma</condition>
  <arm_group>
    <arm_group_label>Healthy individuals</arm_group_label>
    <description>This group is composed of healthy individuals without previous noise exposure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acute acoustic trauma patients</arm_group_label>
    <description>This group is composed of patients suffering from acute acoustic trauma.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hearing test</intervention_name>
    <description>The hearing test is composed of several examinations:&#xD;
pure tone audiogram&#xD;
otoscopy&#xD;
tympanometry&#xD;
Healthy individuals: The hearing test will be performed at enrollment (Day 0). Patients: The hearing test will be performed at Day 1, Day 3, Day 7 and Day 30.</description>
    <arm_group_label>Acute acoustic trauma patients</arm_group_label>
    <arm_group_label>Healthy individuals</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire about previous noise exposure</intervention_name>
    <description>The participant will have to fill in a questionnaire about his/her previous noise exposure at enrollment (Day 0).</description>
    <arm_group_label>Acute acoustic trauma patients</arm_group_label>
    <arm_group_label>Healthy individuals</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Otoacoustic emission measurement</intervention_name>
    <description>Healthy individuals: Otoacoustic emission will be measured at enrollment (Day 0).&#xD;
Patients: Otoacoustic emission will be measured at enrollment (Day 0), at Day 1, Day 3, Day 7 and Day 30.</description>
    <arm_group_label>Acute acoustic trauma patients</arm_group_label>
    <arm_group_label>Healthy individuals</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electrocochleography</intervention_name>
    <description>Healthy individuals: Electrocochleography will be performed at enrollment (Day 0).&#xD;
Patients: Electrocochleography will be performed at Day 30.</description>
    <arm_group_label>Acute acoustic trauma patients</arm_group_label>
    <arm_group_label>Healthy individuals</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Speech audiometry in noise</intervention_name>
    <description>Healthy individuals: Speech audiometry in noise will performed at enrollment (Day 0).&#xD;
Patients: Speech audiometry in noise will performed at enrollment (Day 0), at Day 1, Day 3, Day 7 and Day 30.</description>
    <arm_group_label>Acute acoustic trauma patients</arm_group_label>
    <arm_group_label>Healthy individuals</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multi-frequency impedance measurement</intervention_name>
    <description>Healthy individuals: Multi-frequency impedance will be measured at enrollment (Day 0).&#xD;
Patients: Multi-frequency impedance will be measured at Day 30.</description>
    <arm_group_label>Acute acoustic trauma patients</arm_group_label>
    <arm_group_label>Healthy individuals</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Assessment of tinnitus severity</intervention_name>
    <description>Tinnitus severity will be assessed using a visual analogic scale at enrollment (Day 0), at Day 1, Day 3, Day 7 and Day 30.</description>
    <arm_group_label>Acute acoustic trauma patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood sample collection</intervention_name>
    <description>Healthy individuals: A blood sample will be collected at enrollment (Day 0). Patients: A blood sample will be collected at enrollment (Day 0), at Day 1, Day 3, Day 7 and Day 30.</description>
    <arm_group_label>Acute acoustic trauma patients</arm_group_label>
    <arm_group_label>Healthy individuals</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is composed of healthy individuals who have never been exposed to&#xD;
        noise and patients suffering from acute acoustic trauma.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18 and 40&#xD;
&#xD;
          -  Healthy individuals: without hearing pathology&#xD;
&#xD;
          -  Patients: acute acoustic trauma diagnosis within 72h&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of hearing pathology&#xD;
&#xD;
          -  History of severe head injury&#xD;
&#xD;
          -  Ototoxic drug therapy&#xD;
&#xD;
          -  Abnormal otoscopy and/or tympanometry&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guillaume ANDEOL, MD, PhD</last_name>
    <phone>178651207</phone>
    <phone_ext>+33</phone_ext>
    <email>guillaume.andeol@intradef.gouv.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>43e Antenne Médicale de Sarrebourg</name>
      <address>
        <city>Sarrebourg</city>
        <zip>57404</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre RAJOELISON, MD</last_name>
      <phone>387234509</phone>
      <phone_ext>+33</phone_ext>
      <email>pierre.rajoelison@intradef.gouv.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 1, 2021</study_first_submitted>
  <study_first_submitted_qc>April 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2021</study_first_posted>
  <last_update_submitted>April 15, 2021</last_update_submitted>
  <last_update_submitted_qc>April 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss, Noise-Induced</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

